Bosh sahifaABCL • NASDAQ
add
AbCellera Biologics Inc
Yopilish kursi
4,87 $
Kunlik diapazon
4,76 $ - 4,92 $
Yillik diapazon
1,89 $ - 6,52 $
Bozor kapitalizatsiyasi
1,44 mlrd USD
Oʻrtacha hajm
5,39 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 17,08 mln | 133,29% |
Joriy xarajat | 27,46 mln | -54,13% |
Sof foyda | -34,73 mln | 5,97% |
Sof foyda marjasi | -203,27 | 59,69% |
Har bir ulushga tushum | -0,12 | 7,69% |
EBITDA | -44,11 mln | 22,51% |
Amaldagi soliq stavkasi | 4,45% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 553,08 mln | -17,49% |
Jami aktivlari | 1,40 mlrd | -0,74% |
Jami passivlari | 394,98 mln | 31,00% |
Umumiy kapital | 1,01 mlrd | — |
Tarqatilgan aksiyalar | 298,83 mln | — |
Narxi/balansdagi bahosi | 1,43 | — |
Aktivlardan daromad | -9,03% | — |
Kapitaldan daromad | -11,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -34,73 mln | 5,97% |
Operatsiyalardan naqd pul | -32,40 mln | -8,14% |
Sarmoyadan naqd pul | -31,81 mln | -161,06% |
Moliyadan naqd pul | -3,38 mln | -227,31% |
Naqd pulning sof oʻzgarishi | -66,83 mln | -370,13% |
Boʻsh pul | -61,07 mln | -43,54% |
Haqida
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Tashkil etilgan
2012
Sayt
Xodimlar soni
596
